电邮这篇文章 Relationship between Hedgehog Signaling Pathway and Drug Resistance of Poorly Differentiated Gliomas
- 作者: Cherepanov S.A.1,2, Grinenko N.F.2, Antonova O.M.2, Kurapov P.B.1, Shepeleva I.I.1,2, Chekhonin V.P.1,2
-
隶属关系:
- N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation
- V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
- 期: 卷 164, 编号 3 (2018)
- 页面: 356-361
- 栏目: Article
- URL: https://journal-vniispk.ru/0007-4888/article/view/239597
- DOI: https://doi.org/10.1007/s10517-018-3989-x
- ID: 239597
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
The effects of Hedgehog signaling inhibitor (cyclopamine) and activator (Shh) on drug resistance of U251-MG human glioma cells and human astrocyte culture to cisplatin, temozolomide, and doxorubicin were studied. Cyclopamine and Shh modified the drug resistance of U251-MG cells but not of human astrocytes. Experiments with cyclopamine, Shh, and chemical drugs can contribute to detection of the mechanisms of signaling effects on the drug resistance processes, while the experimental data can serve as one of the criteria for choosing individual chemotherapy for patients.
作者简介
S. Cherepanov
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: cherep-rsmu@yandex.ru
俄罗斯联邦, Moscow; Moscow
N. Grinenko
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
俄罗斯联邦, Moscow
O. Antonova
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
俄罗斯联邦, Moscow
P. Kurapov
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
俄罗斯联邦, Moscow
I. Shepeleva
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
俄罗斯联邦, Moscow; Moscow
V. Chekhonin
N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation; V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: cherep-rsmu@yandex.ru
俄罗斯联邦, Moscow; Moscow
补充文件
